Variation in Use of High-Cost Diabetes Mellitus Medications in the VA Healthcare System

Archives of Internal Medicine
doi 10.1001/archinternmed.2012.4482
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Use of Healthcare Resources After Gestational Diabetes Mellitus: A Longitudinal Case–control Analysis

Scandinavian Journal of Public Health
MedicineEnvironmentalPublic HealthOccupational Health
2012English

Cost Variation of Antipsychotics in the Public Health System in Brazil: The Implication for Health Resource Use

Jornal Brasileiro de Economia da Saúde
2017English

Cost-Minimization Analysis of Linagliptin Compared to Sitagliptin in the Treatment of Type 2 Diabetes Mellitus From a Turkish Healthcare Perspective

Journal of Diabetes & Metabolism
2017English

Contraceptive Provision in the VA Healthcare System to Women Who Report Military Sexual Trauma

Journal of Women's Health
Medicine
2014English

Healthcare Professionals’ Perceptions of Type 2 Diabetes Mellitus Care in the Mediterranean Region

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Cost-Effectiveness of Dapagliflozin Versus DPP-4 Inhibitors as an Add-On to Metformin in the Treatment of Type 2 Diabetes Mellitus From a UK Healthcare System Perspective

BMC Health Services Research
Health Policy
2015English

Discrepancies in the Use of Medications

Archives of Internal Medicine
2000English

Markers of Peripheral Nervous System Lesion in Diabetes Mellitus

Medical Council
2017English

Effects of Diabetes Medications Targeting the Incretin System on the Kidney

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy